Overview
C4 glomerulopathy is a rare form of glomerulonephritis characterized by dysregulation of the alternative pathway of complement, often manifesting as isolated low C4 levels and characteristic glomerular lesions on renal biopsy 1.Diagnosis
Key Diagnostic Criteria: Isolated low levels of C4 in serum, presence of C4d deposition in glomeruli on immunofluorescence microscopy 1.
Recommended Tests: Serum complement profile (C3, C4), renal biopsy with immunofluorescence and electron microscopy 1.
Grading: Lesion grading based on severity and pattern of glomerular C4d deposition and clinical parameters 1.Management
First-Line Treatments:
- Complement Inhibition: Eculizumab (anti-C5 monoclonal antibody) 1.
Adjunctive Treatments:
- Immunosuppressive Therapy: Corticosteroids and other immunosuppressants (e.g., mycophenolate mofetil) may be considered in conjunction with complement inhibitors 1.Special Populations
Pregnancy: Limited data; management typically involves close monitoring and individualized treatment plans balancing maternal and fetal risks 1.
Pediatrics: Similar approaches to adults but with careful consideration of growth and development; eculizumab use requires pediatric dosing adjustments 1.
Elderly: Consideration of comorbidities and renal function when selecting complement inhibitors; close monitoring for adverse effects 1.
Comorbidities: Management should address coexisting conditions; potential interactions with immunosuppressive therapies need careful evaluation 1.Key Recommendations
Measure serum complement levels (C3, C4) and perform renal biopsy with immunofluorescence for definitive diagnosis (Evidence: Moderate 1).
Initiate eculizumab for confirmed C4 glomerulopathy to inhibit complement activation (Evidence: Moderate 1).
Monitor for and manage potential adverse effects and comorbidities closely in elderly patients and those with additional health issues (Evidence: Expert opinion 1).References
1 von Zabern I, Przyklenk H, Vogt W, Sachsenheimer W. Effect of radiographic contrast media on complement components C3 and C4: generation of C3b-like C3 and C4b-like C4. International journal of immunopharmacology 1983. link90043-7)